CLICK PLAY ABOVE to watch our announcement video. Two leading foundations in the field of pediatric brain cancer research funding, Michael Mosier Defeat DIPG Foundation and The ChadTough Foundation, are uniting as one organization, ChadTough Defeat DIPG Foundation, to elevate and amplify their impact on finding a cure for DIPG. In September 2014, two families, […]
https://defeatdipg.org/wp-content/uploads/2021/01/Untitled-design-159.png400600Jenny Mosierhttps://defeatdipg.org/wp-content/uploads/2018/03/DefeatDIPG-Logo-216.pngJenny Mosier2021-01-11 21:13:072021-01-12 11:09:36Michael Mosier Defeat DIPG Foundation and The ChadTough Foundation Announce Union to Form ChadTough Defeat DIPG Foundation
Michael Mosier Defeat DIPG Foundation and The ChadTough Foundation, with their chapters and partner families, are funding two new Fellowships through their grant program, with a total new commitment of $300,000 over two years. The Defeat DIPG ChadTough Fellowships are designed to encourage outstanding scientists to choose a career involving DIPG research, by funding outstanding postdoctoral fellows under […]
https://defeatdipg.org/wp-content/uploads/2020/12/Untitled-design-152.png10801080Jenny Mosierhttps://defeatdipg.org/wp-content/uploads/2018/03/DefeatDIPG-Logo-216.pngJenny Mosier2020-12-28 20:33:482020-12-28 20:33:51Defeat DIPG and ChadTough Award Two New Fellowship Grants for DIPG Research
Michael Mosier Defeat DIPG Foundation, with its chapters and partner families, has made a grant of $100,000 to support the opening of a new Expanded Access Program for ONC201, an experimental drug currently being tested to treat DIPG. From 2018 to 2020, Defeat DIPG has provided $266,666 to support development of ONC201, with a goal […]
https://defeatdipg.org/wp-content/uploads/2020/11/Untitled-design-150.png9001200Jenny Mosierhttps://defeatdipg.org/wp-content/uploads/2018/03/DefeatDIPG-Logo-216.pngJenny Mosier2020-11-05 09:55:442020-11-05 10:19:44New ONC201 Expanded Access Program to Open with Funding from Defeat DIPG and Partners
Michael Mosier Defeat DIPG Foundation and The ChadTough Foundation, with their chapters and partner families, first joined efforts in late 2017 to jointly fund promising research focused on DIPG. In the past three years, the foundations have awarded more than $6.1 million to fund DIPG-specific research projects through their grant program. Three of the initial […]
Michael Mosier Defeat DIPG Foundation and The ChadTough Foundation, with their chapters and partner families, have granted over $600,000 for the Diffuse Midline Glioma – Adaptive Clinical Trial (DMG-ACT), a new collaboration through the Pacific Pediatric Neuro-Oncology Consortium (PNOC) and the DIPG Centre of Expertise in Zurich. This innovative project will support preclinical and clinical […]
Michael Mosier Defeat DIPG Foundation and The ChadTough Foundation Announce Union to Form ChadTough Defeat DIPG Foundation
/in News /by Jenny MosierCLICK PLAY ABOVE to watch our announcement video. Two leading foundations in the field of pediatric brain cancer research funding, Michael Mosier Defeat DIPG Foundation and The ChadTough Foundation, are uniting as one organization, ChadTough Defeat DIPG Foundation, to elevate and amplify their impact on finding a cure for DIPG. In September 2014, two families, […]
Defeat DIPG and ChadTough Award Two New Fellowship Grants for DIPG Research
/in News /by Jenny MosierMichael Mosier Defeat DIPG Foundation and The ChadTough Foundation, with their chapters and partner families, are funding two new Fellowships through their grant program, with a total new commitment of $300,000 over two years. The Defeat DIPG ChadTough Fellowships are designed to encourage outstanding scientists to choose a career involving DIPG research, by funding outstanding postdoctoral fellows under […]
New ONC201 Expanded Access Program to Open with Funding from Defeat DIPG and Partners
/in News /by Jenny MosierMichael Mosier Defeat DIPG Foundation, with its chapters and partner families, has made a grant of $100,000 to support the opening of a new Expanded Access Program for ONC201, an experimental drug currently being tested to treat DIPG. From 2018 to 2020, Defeat DIPG has provided $266,666 to support development of ONC201, with a goal […]
First Round of Fellowship Grants Concludes Successfully
/in News /by Jen DeGregorioMichael Mosier Defeat DIPG Foundation and The ChadTough Foundation, with their chapters and partner families, first joined efforts in late 2017 to jointly fund promising research focused on DIPG. In the past three years, the foundations have awarded more than $6.1 million to fund DIPG-specific research projects through their grant program. Three of the initial […]
Innovative DIPG Trial Opening Soon
/in News /by Jenny MosierMichael Mosier Defeat DIPG Foundation and The ChadTough Foundation, with their chapters and partner families, have granted over $600,000 for the Diffuse Midline Glioma – Adaptive Clinical Trial (DMG-ACT), a new collaboration through the Pacific Pediatric Neuro-Oncology Consortium (PNOC) and the DIPG Centre of Expertise in Zurich. This innovative project will support preclinical and clinical […]